Komshian S V, Uwaydah A K, Sobel J D, Crane L R
Department of Medicine, Wayne State University School of Medicine, Detroit, Michigan.
Rev Infect Dis. 1989 May-Jun;11(3):379-90. doi: 10.1093/clinids/11.3.379.
We reviewed 135 cases of candidemia occurring between 1983 and 1986 to examine oncologic and nononcologic populations and assess factors for survival. Candida albicans was the most common species (51%); Candida tropicalis occurred most frequently in leukemia patients (57%), whereas Candida parapsilosis and Torulopsis glabrata were associated with solid tumors and nononcologic diseases. Risk factors identified were: preceding surgery, antibiotics, cannulas, and steroids in solid tumor and nononcologic diseases; and chemotherapy and neutropenia with hematologic malignancies. Even transient cannula-associated candidemia was not a benign process. Intravenous cannulas were common portals of entry (39%) in debilitated patients without cancer (59%) and were associated with high mortality (55%). Overall mortality was 59%, candidemia directly contributing to death in 75% of cases. In patients with candidemia, failure to initiate therapy with amphotericin B had a negative influence on outcome, whereas analysis of the entire group identified severity of underlying illness as the dominant cofactor influencing outcome.
我们回顾了1983年至1986年间发生的135例念珠菌血症病例,以研究肿瘤患者和非肿瘤患者群体,并评估生存因素。白色念珠菌是最常见的菌种(51%);热带念珠菌在白血病患者中最常出现(57%),而近平滑念珠菌和光滑假丝酵母与实体瘤和非肿瘤性疾病相关。确定的危险因素有:实体瘤和非肿瘤性疾病患者先前接受过手术、使用过抗生素、插管和类固醇;血液系统恶性肿瘤患者接受过化疗和存在中性粒细胞减少症。即使是短暂的与插管相关的念珠菌血症也不是一个良性过程。静脉插管是无癌症的虚弱患者(59%)常见的感染途径(39%),且与高死亡率(55%)相关。总体死亡率为59%,念珠菌血症直接导致75%的病例死亡。在念珠菌血症患者中,未开始使用两性霉素B治疗对预后有负面影响,而对整个群体的分析表明,基础疾病的严重程度是影响预后的主要协同因素。